Investigation of the protective effects of polyphenols on polychlorinated biphenyl-induced inflammation and oxidative stress: impact of biotransformation

点击翻译按钮获取中文摘要

Background: PCB exposure is linked with neurologic damage in offspring of PCB-exposed women, cognitive disorders in children and poorer memory in adults. Despite food as the main source of PCBs, little is known about direct effects of PCBs on the gut cells. The role of gut microflora in PCB biotransformation is sparsely studied. PCB toxicity mediated via oxidative stress might be protected by dietary polyphenols via an antioxidant response induced via the nuclear factor erythroid 2-related factor 2 (Nrf2). Polyphenols, however, are poorly absorbed until they undergo gut microbial biotransformation that leads to more bioavailable secondary metabolites. Polyphenol metabolites may alter metabolism of PCBs and subsequent conjugation pathways that can modulate PCB toxicity. A limitation of existing mechanistic studies using human cell culture studies is the direct use of PCBs or polyphenols on human intestinal, hepatic and neuronal cells without exposure of such compounds to intermediary digestive or metabolic processes. *Research Progress: PCBs and polyphenols separately underwent human simulated in vitro digestion using a Computer Controlled Dynamic Human Gastrointestinal Model (SHGI model) that mimics the different stages of digestion throughout the human GI tract. This model includes the use of colonic vessels containing human microbiota obtained from human fecal samples. Using LC-MS and HPLC, we showed that the common dietary polyphenols led to differing polyphenol metabolite profiles and antioxidant capacities in the ascending, transverse and descending colon vessels of the GI model. We developed Caco-2/HepG2 cell co-cultures to mimic human intestinal and hepatic first pass metabolism. After the GI model colonic digests of the polyphenols were subjected to the biotransformation and absorptive processes of the co-cultures, we detected microbial polyphenol by-products previously noted in plasma of humans ingesting polyphenols. Two structurally different PCB congeners, dioxin-like (PCB-126) and non-dioxin-like PCB (PCB-153), were separately subjected to the GI model as they are dominant congeners in the human diet and in human plasma. The LC-MS profiles of the PCB metabolites generated from the GI model and co-cultures and the human microbiota profiles seen in the GI model after the polyphenol and PCB exposures are being studied.*Objectives: The overall objectives are to combine the GI model with the simulated first pass metabolism co-culture system to: (1) identify biotransformed metabolites of PCBs in the study of mechanisms of PCB-induced toxicity on human intestinal, hepatic and neural cells; and (2) assess the effects of polyphenol microbial metabolites on PCB metabolism and toxicity with a focus on PCB metabolites, oxidative stress, inflammation and the Nrf2 signalling pathway.*Experimental Design: Human intestinal, hepatic and neuronal cells will be exposed to parent PCBs and polyphenols and their metabolites generated by GI model and first pass metabolism system. PCB and polyphenol metabolites will be assessed via LC-MS and HPLC. Cells will be pre-treated with the identified polyphenol metabolites to test for their effects on PCB-mediated metabolism and toxicity. Neural effects will be tested on human neural progenitor cells co-cultured onto a Multiwell insert system with the human brain endothelial capillary cell line hCMEC/D3 as a model for the human blood brain barrier. Cell viability, intracellular reactive oxygen species accumulation and inflammatory cytokines will be measured. Nrf2 levels will be assessed via Western blot. *Significance: This study will provide new insights of PCB-induced inflammation and oxidative-stress as mediated by gut metabolism and interactions with with dietary polyphenols.